Featured
With Recoveries of $671 Million, HealthSouth Set New Lows for Corporate Conduct. And Record Highs for the Ability of Litigation to Even the Score.
Updated: December 20, 2011
HealthSouth was not an average securities fraud litigation.
Sure, the mechanics of the company's fraud – manipulating financial statements with false revenue and income, understating write-offs, capitalizing normal expense, among...
Selected Case Highlights
$624 Million...One of the Largest Securities Settlements Against a Principal Architect of the Mortgage Crisis
Updated: March 13, 2012
In the housing market boom, Countrywide Financial catapulted onto the scene, quickly becoming one of the nation's largest mortgage lenders. To achieve its leading market position, the company shifted away...
$80 Million Settlement and Significant Corporate Governance Reforms – That's How We Respond to a Corporate Culture of Misconduct
Updated: March 13, 2012
Vesta Insurance Group had a history of fraud.
Since the company first went public in 1993 until the middle of 1998, it issued false financial statements to the public. This...
A $300 Million Victory and One of the Largest Secured During the Earliest Stages of a Securities Class Action
Updated: March 13, 2012
In one of the largest settlements ever secured in the early stages of a securities fraud case, Labaton Sucharow, as co-lead counsel for the plaintiffs, recovered more than $300 million...
A Billion Dollar Recovery for Class Members and Accountability from Wall Street
Updated: April 26, 2012
On behalf of our clients, we demand accountability from Wall Street. We will litigate against one of the world’s largest insurers to fight for our cause and win.
A Global Price-Fixing Scheme with 50 Defendants Spanning Six Continents. Almost Half A Billion Dollars Recovered...And We're Just Getting Started.
Updated: March 13, 2012
While Labaton Sucharow is regularly appointed by the courts to prosecute high profile antitrust class actions, some cases stand out for their breadth of wrongdoing, the scope of the litigation...
A Message for Big Pharma: A 400% Price Hike on Life-Changing Medication? Anticompetitive. And Unconscionable.
Updated: March 13, 2012
In 1996, pharmaceutical giant Abbott Laboratories introduced Norvir, a new drug that revolutionized HIV treatment options. When taken in combination with other drugs, including those produced by Abbott's competitors, Norvir acted as a powerful...
Achieving Extraordinary Results Across Borders in an Egregious Case of Securities Fraud
Updated: September 30, 2011
When companies fail to meet the most elementary auditing standards and misrepresent their values to their investors, Labaton Sucharow will fight to obtain recoveries that match such egregious actions.
Anti Trust Case
Updated: June 08, 2011
Test content for this Case study
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Donec scelerisque, arcu vestibulum porta placerat, massa tellus pulvinar lectus, et rhoncus tellus odio nec sapien....
Anti Trust Case
Updated: June 17, 2011
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nulla a lorem diam. Ut auctor, nulla et mollis pretium, turpis nulla lacinia nisl, at bibendum turpis sapien vitae arcu. Suspendisse id...
Capturing the Crown Jewel of the Credit Crisis: $275 Million with Bear Stearns and $19.9 Million with Auditor Deloitte & Touche
Updated: March 04, 2013
The Firm chalked up another victory in its complex case against Bear Stearns and its auditors, one of the key pieces of litigation to arise from the financial crisis. The...
Class Action Forces Corporate Wrongdoer to Come Clean
Updated: March 13, 2012
In the late 1990s, Fortune 500 giant Waste Management, Inc. became embroiled in a number of corporate scandals relating to its merger with USA Waste Services. The company misstated its...
Cleaning Up A Dirty Energy Deal
Updated: March 21, 2013
When El Paso Corporation and Kinder Morgan, Inc. announced their proposed $21.1 billion merger, it raised eyebrows at Labaton Sucharow.
The proposed merger was being touted to El Paso's...
Shareholders Stand Up to High-Tech Giant
Updated: December 20, 2011
In 2006, people started to notice that something wasn't right at Broadcom.
Analysts at two separate banks pointed to questionable activity at the California high-tech company and soon after, the...
Successful Class Actions Against Mutual Funds are Rare---and a Combined Recovery of $100 Million for Investors to Boot
Updated: May 25, 2012
The relationship between an investor and an asset manager is based on trust and transparency. So when investors find out that their conservative investments were hedging on undisclosed high risk...
Taking on Energy Giants to End Widespread Market Manipulation
Updated: March 13, 2012
During 2000-2002, some of the largest energy companies in the country manipulated the price of natural gas futures traded on the New York Mercantile Exchange. These companies not only falsely...
Taming the (Options Backdating) Monster
Updated: March 13, 2012
In 2008, Labaton Sucharow won a major victory in an options backdating action against internet behemoth Monster Worldwide, securing what was, at the time, one of the largest settlements in...
The REAL Deal: The First Case Tried to a Jury Verdict Following the Enactment of the PSLRA: A Landmark Victory. A Firm of Firsts.
Updated: March 22, 2012
The Real Estate Associates Limited Partnerships ("REAL Partnerships") were supposedly attractive investment vehicles created between 1977-1984 to acquire interests in affordable housing projects. With the government providing competitive financing and...
When a Pharma Giant's Quest for Blockbuster Drug Profits Threatened Shareholders and Consumers Alike, We Fought Back. And Won.
Updated: March 13, 2012
In 1999, after extensive clinical trials, Bristol-Myers Squibb (BMS) announced the promising results of its developmental blood pressure drug Vanlev. The company's press release reported that while Vanlev had side...
When Corporate Integrity Takes Flight
Updated: March 22, 2012
Let's just say the 21st century didn't launch smoothly for the financial markets. To be sure, in the wake of Enron and WorldCom, the public was dizzied and disenchanted with...
With Recoveries of $671 Million, HealthSouth Set New Lows for Corporate Conduct. And Record Highs for the Ability of Litigation to Even the Score.
Updated: December 20, 2011
HealthSouth was not an average securities fraud litigation.
Sure, the mechanics of the company's fraud – manipulating financial statements with false revenue and income, understating write-offs, capitalizing normal expense, among...